Wyeth Ltd(Merged)
Wyeth Limited is an India-based biopharmaceutical company. The company is engaged in manufacturing, marketing, trading and export of pharmaceuticals and consumer healthcare products.
- Market Cap ₹ Cr.
- Current Price ₹ 1,334
- High / Low ₹ /
- Stock P/E
- Book Value ₹ 108
- Dividend Yield 0.00 %
- ROCE %
- ROE %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- Stock is trading at 12.3 times its book value
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Multinational
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2006 | |
|---|---|
| 286 | |
| 213 | |
| Operating Profit | 73 |
| OPM % | 25% |
| 18 | |
| Interest | 0 |
| Depreciation | 6 |
| Profit before tax | 84 |
| Tax % | 19% |
| 68 | |
| EPS in Rs | 29.83 |
| Dividend Payout % | 84% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2006 | |
|---|---|
| Equity Capital | 23 |
| Reserves | 223 |
| 2 | |
| 106 | |
| Total Liabilities | 354 |
| 47 | |
| CWIP | 0 |
| Investments | 0 |
| 306 | |
| Total Assets | 354 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2006 | |
|---|---|
| 61 | |
| 11 | |
| -52 | |
| Net Cash Flow | 20 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2006 | |
|---|---|
| Debtor Days | 25 |
| Inventory Days | 168 |
| Days Payable | 97 |
| Cash Conversion Cycle | 97 |
| Working Capital Days | 4 |
| ROCE % |
Documents
Announcements
No data available.